Podcasts about rhinosinusitis

Drückende Kopfschmerzen, eine verstopfte Nase, das Atmen fällt schwer, das Essen schmeckt nach nichts – die typischen Symptome einer Erkältung oder Coronainfektion. Zum Glück verschwinden sie meistens ein paar Tage später. Bei Stefan aber nicht, denn die Ursache ist eine andere: 22 Jahre lang leidet er unter einer chronischen Rhinosinusitis mit Nasenpolypen, kurz CRSwNP. Heute ist er so gut wie beschwerdefrei. Wir sprechen mit Stefan über Symptom-Frust und seinen Weg mit der chronischen Erkrankung. Außerdem erklärt HNO-Ärztin Dr. Sonja Spahn, welche Ursachen hinter der chronischen Rhinosinusitis mit Nasenpolypen stecken, alles über die Diagnosestellung und wie neue Therapieoptionen die Behandlung entscheidend verbessern können.

In this episode, host Dr. Marc Dubin speaks with Dr. Vinay Rathi. They discuss the recently published Research Note: Spending, utilization, and coverage for chronic rhinosinusitis with nasal polyposis therapies among Medicare Advantage beneficiaries. Read the full article in the International Forum of Allergy and Rhinology. Listen and subscribe for free to Scope It Out […]

Klinisch Relevant ist Dein Wissenspartner für das Gesundheitswesen. Drei mal pro Woche, nämlich dienstags, donnerstags und samstags, versorgen wir Dich mit unserem Podcast und liefern Dir Fachwissen für Deine klinische Praxis. Weitere Infos findest Du unter https://klinisch-relevant.de

In this episode, host Dr. Doug Reh speaks with Dr. Rod Schlosser. They discuss the recently published article: Surgical management of headache and facial pain/pressure in chronic rhinosinusitis: A systematic review and meta-analysis. Read the article in the International Forum of Allergy and Rhinology. Listen and subscribe for free to Scope It Out on Apple Podcasts, Google […]

In this episode, host Dr. Amber Luong speaks with Dr. Sarina Mueller They discuss the recently published article: Comparison of mucus and serum biomarker sampling in chronic rhinosinusitis with nasal polyps. Read the fully open access article in the International Forum of Allergy and Rhinology. Listen and subscribe for free to Scope It Out on Apple […]

JACI: In Practice Editor Michael Schatz describes the April issue, the theme of which is “Newer Approaches to Asthma Management”. Theme topics covered include phenotyping severe asthma in the current era of biologics, management of extrapulmonary treatable traits, downstream impacts of systemic inflammation in patients with asthma, the relationship to asthma and therapeutic potential of alterations in the respiratory and gut microbiome, the new paradigm of inhaled corticosteroid use as part of reliever therapy, and the recently articulated goal of achieving disease remission. Dr. Schatz then presents the Highlights of the Original Articles in the issue, which are on the topics of Asthma, Drug Allergy, Eosinophilic disorders, Food Allergy, Hereditary Angioedema, Immunodeficiency, and Rhinosinusitis.

Nasal spray approved for chronic rhinosinusitis; Endothelin receptor antagonist gains approval to lower blood pressure in hypertension; One-time stem cell treatment approved for metachromatic leukodystrophy; NASH treatment gains accelerated approval; New automated insulin delivery system for type 1 diabetes.  

In this episode, host Dr. Sarah Wise speaks with Dr. Amarbir Gill. They discuss his recently published article: Health care disparities and chronic rhinosinusitis: Does neighborhood disadvantage impact outcomes in sinonasal disease? Read the article in the International Forum of Allergy and Rhinology. Listen and subscribe for free on Apple Podcasts , Google Podcasts and Subscribe on Android.

In this episode, host Dr. Amber Luong speaks with Dr. Ahmad Sedaghat. They discuss his recently published article: Determinants of physician assessment of chronic rhinosinusitis disease control using EPOS 2020 criteria and the importance of incorporating patient perspectives of disease control. Read the article in the International Forum of Allergy and Rhinology. Listen and subscribe […]

In this episode, host Dr. Marc Dubin speaks with Dr. Gurston Nyquist. They discuss his recently published article: Optimizing the timing of biologic and surgical therapy for patients with refractory chronic rhinosinusitis with nasal polyposis (CRSwNP). Read the article in the International Forum of Allergy and Rhinology. Listen and subscribe for free on Apple Podcasts , Google Podcasts and Subscribe […]

Credits: 0.50 AMA PRA Category 1 Credits™, 0.50 ABIM MOC or 0.65 AANP, including 0.65 AANP Pharm   CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/Podcast/acute-bacterial-rhinosinusitis    Overview: In this 30-minute podcast tailored for medical professionals, navigate the nuances of Acute Bacterial Rhinosinusitis (ABRS) as expert faculty discuss differentiating symptoms from acute rhinosinusitis. Gain practical insights on constructing effective treatment plans for ABRS in adults and acute bacterial sinusitis in pediatric populations, offering valuable guidance for appropriate antibiotic use in these scenarios. Stay informed and enhance your clinical decision-making skills in managing these common conditions.   Guest: Danielle Hebert, DNP, MBA, ANP-BC

In this episode, host Dr. Sarah Wise speaks with Dr. Bobby Tajudeen. They discuss his recently published article: Histopathologic features of biologic therapy nonresponders in chronic rhinosinusitis with nasal polyposis. Read the article in the International Forum of Allergy and Rhinology. Listen and subscribe for free on Apple Podcasts , Google Podcasts and Subscribe on Android.

On this episode, my good friend and colleague Alex Hovey, PA-C is sitting in for Cole this episode. We review the treatment of acute rhinosinusitis and pharyngitis. We mention some treatment options for symptom relief in patients with viral sinusitis and viral pharyngitis. We spend the majority of the episode covering the treatment algorithm for bacterial sinusitis and pharyngitis. We also used this episode to review some antibiotic clinical pearls.  Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website: https://www.freece.com/ If you're not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast. Thanks for listening! We want to give a big thanks to our sponsor, High-Powered Medicine. HPM is a book/website database of summaries for over 150 landmark clinical trials. You can get a copy of HPM, written by Dr. Alex Poppen, PharmD, at the links below:  Purchase a subscription or PDF copy - https://highpoweredmedicine.com/ Purchase the paperback and hardcover - Barnes and Noble website We want to give a big thanks to our main sponsor Pyrls. Try out their drug information app today. Visit the website below for a free trial: www.pyrls.com/corconsultrx If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. You can find our account at the website below:  www.patreon.com/corconsultrx If you have any questions for Cole or me, reach out to us on any of the following: Text - 415-943-6116 Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com Instagram and other social media platforms - @corconsultrx  This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.

JACI: In Practice Editor Dave Khan describes the November issue, the theme of which is “COVID-19 and Allergy/Immunology”. Theme topics covered include the impact of COVID-19 on common allergic diseases, COVID-19 vaccine reactions, COVID-19 treatments, long COVID, social determinants of health and COVID-19, social media and COVID-19, physician and patient wellness during the pandemic, and preparing the allergist/immunologist for the next pandemic. Dr. Khan then presents the Highlights of the Original Articles in the issue, which are on the topics of COVID-19, Anaphylaxis, Asthma,  Drug Allergy, Food Allergy, Immunodeficiency, Rhinosinusitis, and Urticaria

In this episode, host Dr. Doug Reh speaks with Dr. Lauren Roland and Dr. Edward Kuan. They discuss their recently published article: Diagnosis, Prognosticators, and Management of Acute Invasive Fungal Rhinosinusitis: Multidisciplinary Consensus Statement and Evidence-Based Review with Recommendations Read the article in the International Forum of Allergy and Rhinology. Listen and subscribe for free […]

In this episode, host Dr. Mark Dubin speaks with Dr. Jose Mattos and Dr. Spencer Payne. They discuss their recently published article: Evaluation and workup of immunodeficiencies in recurrent acute rhinosinusitis: A scoping review. Please note that an unedited version of this episode posted in error earlier this month. Wiley sincerely apologizes for this error. […]

Commissioned by the Allergy, Asthma and Immunology Committee, Joshua M Levy, MD, MPH and Bruce K. Tan, MD discuss mechanisms and biomarkers of endotypes in chronic rhinosinusitis. Subjects covered by this podcast include identification of types of inflammation, geographic variations in endotypes, and methods utilized to address different endotypes.

Die andauernde Entzündung der Schleimhäute von Nasen und Nasennebenhöhlen ist eine der häufigsten chronischen Entzündungen überhaupt. Dennoch wird weiterhin eifrig nach den Ursachen und Auslösern gesucht und das Repertoire an Therapien weiterentwickelt. So geht es in diesem Expertenpodcast auch um die Frage, was von den neuen Biologika zu halten ist. Als Experten zu Gast sind die HNO-Ärzte Frau Prof. Dr. Julia Eckl-Dorna und Herr Priv--Doz. Dr. Sven Schneider (beide MedUni Wien). Die Fragen stellt Martin Burger

JAMA Pediatrics Editors' Summary by Dimitri A. Christakis, MD, MPH, Editor in Chief, and Alison A. Galbraith, MD, MPH, Associate Editor, for the April 3, 2023, issue. Related Content: Effect of an Intranasal Corticosteroid on Quality of Life and Local Microbiome in Young Children With Chronic Rhinosinusitis Changes in Body Mass Index Among School-Aged Youths Following Implementation of the Healthy, Hunger-Free Kids Act of 2010

Matt Rank, MD, FAAAAI, the lead author of new guidelines for chronic rhinosinusitis with nasal polyposis, offers tremendous insight regarding these recommendations and how to apply them to clinical care.

Auf und in unserem Körper leben zahlreiche Mikroorganismen, ohne dass wir davon sehr viel bemerken. Dennoch ist das Mikrobiom sehr wichtig für unsere Gesundheit. Warum das so ist, erklärt PTA Beiratsmitglied Britta Fröhling im Gespräch mit Chefredakteurin Julia Pflegel. (14:48 Min) https://www.das-pta-magazin.de/news/podcast-pta-funk-mikrobiom-wir-sind-nie-allein-3283999.html

Deadly fungus!   This can kill a patient fast.   Can you recognize the imaging features in time?  In this week's podcast, Dr. Ross Frederick summarizes a very important paper on Invasive Fungal Sinusitis- don't miss this one! Deadly Fungi: Invasive Fungal Rhinosinusitis in the Head and Neck. Kurokawa and Kurokawa et al. RadioGraphics 2022; 42:2075–2094.  

Nase zu? Hilfe gibt's aus der Apotheke. Rezepturprofi Sarah Siegler aus den Ertelt-Apotheken in Bisingen tauscht sich mit Redakteurin Stefanie Fastnacht über die defekturmäßige Herstellung einer Nasensalbe mit Menthol und Eucalyptusöl aus. (14:44 Min) https://www.das-pta-magazin.de/news/podcast-pta-funk-defektur-nasensalbe-auf-vorrat-3278419.html

In this episode, host Dr. Amber Luong speaks with Dr. Amar Miglani. They will discuss article: A comparative analysis of endoscopic sinus surgery versus biologics for treatment of chronic rhinosinusitis with nasal polyposis. Read the article in International Forum of Allergy and Rhinology. Listen and subscribe for free on Apple Podcasts , Google Podcasts and Subscribe on Android.

Go online to PeerView.com/TJV860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Chronic rhinosinusitis with nasal polyps (CRSwNP) is one phenotype of CRS that is driven by type 2 inflammation and is particularly difficult to manage, especially when it occurs comorbidly with asthma, as is the case in up to 60% of patients with CRSwNP. However, biological agents that target type 2 inflammation and are already approved for other indications (eg, asthma, atopic dermatitis) have begun to emerge as available therapeutic options for CRSwNP. In this activity, Dr. Anju T. Peters shares her expertise in optimal clinical decision-making for patients with CRSwNP that is based on the latest evidence, best practice recommendations, and effective interdisciplinary collaboration. Upon completion of this activity, participants should be better able to: Identify patients with severe, inadequately controlled CRSwNP who would derive benefit from targeted biologic therapy; Assess patients with CRSwNP for comorbid conditions such as asthma and atopic dermatitis based on the relationship between CRSwNP and other type 2 inflammatory disorders; Employ a multidisciplinary approach to the treatment of patients with CRSwNP according to practice guidelines and the latest clinical evidence

Go online to PeerView.com/TJV860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Chronic rhinosinusitis with nasal polyps (CRSwNP) is one phenotype of CRS that is driven by type 2 inflammation and is particularly difficult to manage, especially when it occurs comorbidly with asthma, as is the case in up to 60% of patients with CRSwNP. However, biological agents that target type 2 inflammation and are already approved for other indications (eg, asthma, atopic dermatitis) have begun to emerge as available therapeutic options for CRSwNP. In this activity, Dr. Anju T. Peters shares her expertise in optimal clinical decision-making for patients with CRSwNP that is based on the latest evidence, best practice recommendations, and effective interdisciplinary collaboration. Upon completion of this activity, participants should be better able to: Identify patients with severe, inadequately controlled CRSwNP who would derive benefit from targeted biologic therapy; Assess patients with CRSwNP for comorbid conditions such as asthma and atopic dermatitis based on the relationship between CRSwNP and other type 2 inflammatory disorders; Employ a multidisciplinary approach to the treatment of patients with CRSwNP according to practice guidelines and the latest clinical evidence

Go online to PeerView.com/TJV860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Chronic rhinosinusitis with nasal polyps (CRSwNP) is one phenotype of CRS that is driven by type 2 inflammation and is particularly difficult to manage, especially when it occurs comorbidly with asthma, as is the case in up to 60% of patients with CRSwNP. However, biological agents that target type 2 inflammation and are already approved for other indications (eg, asthma, atopic dermatitis) have begun to emerge as available therapeutic options for CRSwNP. In this activity, Dr. Anju T. Peters shares her expertise in optimal clinical decision-making for patients with CRSwNP that is based on the latest evidence, best practice recommendations, and effective interdisciplinary collaboration. Upon completion of this activity, participants should be better able to: Identify patients with severe, inadequately controlled CRSwNP who would derive benefit from targeted biologic therapy; Assess patients with CRSwNP for comorbid conditions such as asthma and atopic dermatitis based on the relationship between CRSwNP and other type 2 inflammatory disorders; Employ a multidisciplinary approach to the treatment of patients with CRSwNP according to practice guidelines and the latest clinical evidence

Go online to PeerView.com/TJV860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Chronic rhinosinusitis with nasal polyps (CRSwNP) is one phenotype of CRS that is driven by type 2 inflammation and is particularly difficult to manage, especially when it occurs comorbidly with asthma, as is the case in up to 60% of patients with CRSwNP. However, biological agents that target type 2 inflammation and are already approved for other indications (eg, asthma, atopic dermatitis) have begun to emerge as available therapeutic options for CRSwNP. In this activity, Dr. Anju T. Peters shares her expertise in optimal clinical decision-making for patients with CRSwNP that is based on the latest evidence, best practice recommendations, and effective interdisciplinary collaboration. Upon completion of this activity, participants should be better able to: Identify patients with severe, inadequately controlled CRSwNP who would derive benefit from targeted biologic therapy; Assess patients with CRSwNP for comorbid conditions such as asthma and atopic dermatitis based on the relationship between CRSwNP and other type 2 inflammatory disorders; Employ a multidisciplinary approach to the treatment of patients with CRSwNP according to practice guidelines and the latest clinical evidence

Go online to PeerView.com/TJV860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Chronic rhinosinusitis with nasal polyps (CRSwNP) is one phenotype of CRS that is driven by type 2 inflammation and is particularly difficult to manage, especially when it occurs comorbidly with asthma, as is the case in up to 60% of patients with CRSwNP. However, biological agents that target type 2 inflammation and are already approved for other indications (eg, asthma, atopic dermatitis) have begun to emerge as available therapeutic options for CRSwNP. In this activity, Dr. Anju T. Peters shares her expertise in optimal clinical decision-making for patients with CRSwNP that is based on the latest evidence, best practice recommendations, and effective interdisciplinary collaboration. Upon completion of this activity, participants should be better able to: Identify patients with severe, inadequately controlled CRSwNP who would derive benefit from targeted biologic therapy; Assess patients with CRSwNP for comorbid conditions such as asthma and atopic dermatitis based on the relationship between CRSwNP and other type 2 inflammatory disorders; Employ a multidisciplinary approach to the treatment of patients with CRSwNP according to practice guidelines and the latest clinical evidence

Go online to PeerView.com/TJV860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Chronic rhinosinusitis with nasal polyps (CRSwNP) is one phenotype of CRS that is driven by type 2 inflammation and is particularly difficult to manage, especially when it occurs comorbidly with asthma, as is the case in up to 60% of patients with CRSwNP. However, biological agents that target type 2 inflammation and are already approved for other indications (eg, asthma, atopic dermatitis) have begun to emerge as available therapeutic options for CRSwNP. In this activity, Dr. Anju T. Peters shares her expertise in optimal clinical decision-making for patients with CRSwNP that is based on the latest evidence, best practice recommendations, and effective interdisciplinary collaboration. Upon completion of this activity, participants should be better able to: Identify patients with severe, inadequately controlled CRSwNP who would derive benefit from targeted biologic therapy; Assess patients with CRSwNP for comorbid conditions such as asthma and atopic dermatitis based on the relationship between CRSwNP and other type 2 inflammatory disorders; Employ a multidisciplinary approach to the treatment of patients with CRSwNP according to practice guidelines and the latest clinical evidence

Go online to PeerView.com/ZFR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this interactive activity, an expert in chronic rhinosinusitis with nasal polyps discusses how to identify and develop treatment plans for patients with the disease. With a focus on multidisciplinary care and treatment guidelines, the activity will test learners' knowledge about the latest biologic therapies. Upon completion of this activity, participants should be better able to: Identify patients with severe, inadequately controlled CRSwNP to determine eligibility for targeted biologic therapy; Assess patients with CRSwNP for comorbid conditions such as asthma and atopic dermatitis based on the relationship between CRSwNP and other type 2 inflammatory disorders; and Develop treatment plans for patients with CRSwNP according to practice guidelines and the latest clinical evidence as part of a multidisciplinary approach.

Go online to PeerView.com/ZFR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this interactive activity, an expert in chronic rhinosinusitis with nasal polyps discusses how to identify and develop treatment plans for patients with the disease. With a focus on multidisciplinary care and treatment guidelines, the activity will test learners' knowledge about the latest biologic therapies. Upon completion of this activity, participants should be better able to: Identify patients with severe, inadequately controlled CRSwNP to determine eligibility for targeted biologic therapy; Assess patients with CRSwNP for comorbid conditions such as asthma and atopic dermatitis based on the relationship between CRSwNP and other type 2 inflammatory disorders; and Develop treatment plans for patients with CRSwNP according to practice guidelines and the latest clinical evidence as part of a multidisciplinary approach.

Go online to PeerView.com/ZFR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this interactive activity, an expert in chronic rhinosinusitis with nasal polyps discusses how to identify and develop treatment plans for patients with the disease. With a focus on multidisciplinary care and treatment guidelines, the activity will test learners' knowledge about the latest biologic therapies. Upon completion of this activity, participants should be better able to: Identify patients with severe, inadequately controlled CRSwNP to determine eligibility for targeted biologic therapy; Assess patients with CRSwNP for comorbid conditions such as asthma and atopic dermatitis based on the relationship between CRSwNP and other type 2 inflammatory disorders; and Develop treatment plans for patients with CRSwNP according to practice guidelines and the latest clinical evidence as part of a multidisciplinary approach.

Go online to PeerView.com/ZFR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this interactive activity, an expert in chronic rhinosinusitis with nasal polyps discusses how to identify and develop treatment plans for patients with the disease. With a focus on multidisciplinary care and treatment guidelines, the activity will test learners' knowledge about the latest biologic therapies. Upon completion of this activity, participants should be better able to: Identify patients with severe, inadequately controlled CRSwNP to determine eligibility for targeted biologic therapy; Assess patients with CRSwNP for comorbid conditions such as asthma and atopic dermatitis based on the relationship between CRSwNP and other type 2 inflammatory disorders; and Develop treatment plans for patients with CRSwNP according to practice guidelines and the latest clinical evidence as part of a multidisciplinary approach.

Go online to PeerView.com/ZFR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this interactive activity, an expert in chronic rhinosinusitis with nasal polyps discusses how to identify and develop treatment plans for patients with the disease. With a focus on multidisciplinary care and treatment guidelines, the activity will test learners' knowledge about the latest biologic therapies. Upon completion of this activity, participants should be better able to: Identify patients with severe, inadequately controlled CRSwNP to determine eligibility for targeted biologic therapy; Assess patients with CRSwNP for comorbid conditions such as asthma and atopic dermatitis based on the relationship between CRSwNP and other type 2 inflammatory disorders; and Develop treatment plans for patients with CRSwNP according to practice guidelines and the latest clinical evidence as part of a multidisciplinary approach.

Go online to PeerView.com/ZFR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this interactive activity, an expert in chronic rhinosinusitis with nasal polyps discusses how to identify and develop treatment plans for patients with the disease. With a focus on multidisciplinary care and treatment guidelines, the activity will test learners' knowledge about the latest biologic therapies. Upon completion of this activity, participants should be better able to: Identify patients with severe, inadequately controlled CRSwNP to determine eligibility for targeted biologic therapy; Assess patients with CRSwNP for comorbid conditions such as asthma and atopic dermatitis based on the relationship between CRSwNP and other type 2 inflammatory disorders; and Develop treatment plans for patients with CRSwNP according to practice guidelines and the latest clinical evidence as part of a multidisciplinary approach.

Go online to PeerView.com/ZFR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this interactive activity, an expert in chronic rhinosinusitis with nasal polyps discusses how to identify and develop treatment plans for patients with the disease. With a focus on multidisciplinary care and treatment guidelines, the activity will test learners' knowledge about the latest biologic therapies. Upon completion of this activity, participants should be better able to: Identify patients with severe, inadequately controlled CRSwNP to determine eligibility for targeted biologic therapy; Assess patients with CRSwNP for comorbid conditions such as asthma and atopic dermatitis based on the relationship between CRSwNP and other type 2 inflammatory disorders; and Develop treatment plans for patients with CRSwNP according to practice guidelines and the latest clinical evidence as part of a multidisciplinary approach.

Go online to PeerView.com/ZFR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this interactive activity, an expert in chronic rhinosinusitis with nasal polyps discusses how to identify and develop treatment plans for patients with the disease. With a focus on multidisciplinary care and treatment guidelines, the activity will test learners' knowledge about the latest biologic therapies. Upon completion of this activity, participants should be better able to: Identify patients with severe, inadequately controlled CRSwNP to determine eligibility for targeted biologic therapy; Assess patients with CRSwNP for comorbid conditions such as asthma and atopic dermatitis based on the relationship between CRSwNP and other type 2 inflammatory disorders; and Develop treatment plans for patients with CRSwNP according to practice guidelines and the latest clinical evidence as part of a multidisciplinary approach.

Refer to headmirror.com (www.headmirror.com/toc-podcast) to review all podcasts, organized by subspecialty topic and searchable by keywords.

In this episode, host Dr. Doug Reh speaks with Dr. Rod Schlosser. They will discuss article: Eustachian tube dysfunction (ETD) in chronic rhinosinusitis with comparison to primary ETD: A systematic review and meta-analysis. Read the article in International Forum of Allergy and Rhinology. Listen and subscribe for free on Apple Podcasts , Google Podcasts and Subscribe on Android.

In this episode, host Dr. Amber Luong speaks with Dr. Naweed Chowdhury. They will discuss article: Association of cytokine profile with prior treatment failure and revision surgery in chronic rhinosinusitis. Read the article in International Forum of Allergy and Rhinology. Listen and subscribe for free on Apple Podcasts , Google Podcasts and Subscribe on Android.

In episode 514, James and Mike invite Betsy Thomas to the podcast for the first time. We look at a very common condition that many of us have at some point in our lives – allergic rhinosinusitis. We go over the best available evidence for the oral antihistamines and try to figure out which one […]

Are you someone who has never had allergies before and is feeling the effect? Allergy season is stronger than ever before. Learn more about NAC, a supplement that can help with your allergies today! Take advantage of an exclusive podcast offer today by visiting http://www.invitehealth.com/podcast. For more information on the products or studies mentioned in this episode, as well as a complete transcript of the audio, click here. 

Refer to headmirror.com (www.headmirror.com/toc-podcast) to review all podcasts, organized by subspecialty topic and searchable by keywords.

In this episode, host Dr. Amber Luong speaks with Dr. Ralph Metson. They will discuss article: Endoscopic sinus surgery for chronic rhinosinusitis: 22-item Sino-Nasal Outcome Test 5-year results. Read the article in International Forum of Allergy and Rhinology. Listen and subscribe for free on Apple Podcasts , Google Podcasts and Subscribe on Android.

This episode covers nasal polyps.Written notes can be found at https://zerotofinals.com/surgery/ent/nasalpolyps/ or in the ear, nose and throat section of the Zero to Finals surgery book.The audio in the episode was expertly edited by Harry Watchman.

This week we dive into rhinosinusitis exploring the recommendations of who needs antibiotics and who doesn't. https://media.blubrry.com/coreem/content.blubrry.com/coreem/Episode_144_0_Final_Cut.m4a Download Leave a Comment Tags: Acute Bacterial Sinusitis, ENT, Sinusitis Show Notes Take Home Points Acute rhinosinusitis is a clinical diagnosis The vast majority of acute rhinosinusitis cases are viral in nature and do not require antibiotics Consider the use of antibiotics in select groups with severe disease or worsening symptoms after initial improvement. Read More Core EM: Acute Rhinosinusitis TheNNT.com: Antibiotics for Clinically Diagnosed Acute Sinusitis in Adults TheNNT.com: Antibiotics for Radiologically-Diagnosed Acute Maxillary Sinusitis Read More